Blue and red light acne in acne therapy

Bibliography:
1. European evidence-based (S3) guidelines for the treatment of acne//JEADV 2012. №2(suppl.1). P. 1-29; 2. Alster T.S., Bettencourt M.S. Review of cutaneous lasers and their applications // South. Med. J. 1998. № 91. R. 806-814; 3. Lou W. W., Geronemus R. G. Dermatologic laser surgery // Semin.Cutan. Med. Surg. 2002. № 21. R. 107-128; 4. Leyden J.J. Therapy for acne vulgaris // N. Engl. J. Med. 1997. №336. R. 1156-1162; 5. Del Rosso J.Q. Acne in the adolescent patient: interrelationship of psychological impact and therapeutic options // Today. Ther. Trends. 2001. № 19. R. 473-484; 6. Byre P. A. C, Williams B.D., Prichard M.H. Minocy-cline-related lupus// Br. J. Rheumatol. 1994. № 33. R. 674-676; 7. Gough A., Chpman S., Wagstaff K. Minocycline induced autoimmune hepatitis and systemic lupus erythematous-like syndrome//Br. Med. J. 1996. №312. R. 169-172; 8. Moretti M. The Market for Advanced Light-Based Dermatology Treatments // California: Medical Insight, April 2002; 9. Konig K., Ruck A., Schneckenburger H. Fluorescence detection and photodynamic activity of endogenous protoporphyrin in human skin//Opt. Eng. 1992. №31. R. 1470-1474; 10. Holland K.T., Aldana O., Bojar R.A. Propionibacterium acnes and acne // Dermatology 1998. № 196. R. 67-68; 11. Ashkenazi H., Malik Z., Harth Y, Nitzan Y Eradication of Propionibacterium acnes by its endogenic porphyrins after illumination with high intensity blue light // FEMS Immunol. Med. Microbiol. 2003. № 35. R. 17-24; 12. Manyak MJ. Photodynamic therapy: present concepts and future applications//Cancer. J. 1990. №3. R. 104-109; 13. Maclean M., MacGregor S. J., Anderson J.G., Wool-sey G. In vitro bactericidal effects of 405-nm and 470-nm blue light// J.Amer. Soc. for Micro. 2009. №7. R. 1932-1937; 14. Von Tappeiner H., Jodblauer A. Uber die wirkung der photodynamischen (fluorescierenden) stoffe auf protozoen und enzyme // Dtsch. Arch. Klin. Med. 1904. № 80. R. 427-487; 15. Passow A., Rimpau W Untersuchngen uber photody-namischc wirkungen auf bakterien // Munc.Med. Wochenschr. 1924. №23. R. 733-737; 16. Meffert H., Gaunitz K., Gutewort T, Amlong U.J. Therapy of acne with visible light: decreased irradiation time by using a blue-light high energy lamp // Dermatol. Monatssehr. 1990. № 17. R. 597-603; 17. Papageorgiou P., Katsambas A., Chu A. Phototherapy with blue (415 nm) and red (660 nm) light in the treatment of acne vulgaris// Br. J. Dermatol. 2000. № 142. R. 973-978; 18. Ammad S., Edwards O, Gonzalez M., Mills CM. The effect of blue light phototherapy on mild to moderate acne // Br. J. Dermatol. 2002. № 147 (Suppl. 62). P. 95; 19. Kawada A., Aragane Y, Kameyama H., Sangen Y, Tezu-ka T. Acne phototherapy with a high-intensity, enhanced, narrowband, blue light source: An open study and in vitro investigation // J. Dermatol. Sci. 2002. № 30. R. 129-135; 20. Elman M., Slatkine M., Harth Y. The effective treatment of acne vulgaris by a high-intensity, narrow band 405-420 nm light source//J. Cosmet. Laser. Ther. 2003. №5. R. 111-116; 21. Tzung T. Y, Wu K. H., Huang M. L. Blue light phototherapy in the treat-ment of acne // Photodermatol.Photoimmunol.Pho-tomed. 2004. № 20. R. 266-269; 22. 420 nm intense continuous light therapy for acne / T. Omi, P. Bjerring, S. Sato [et al.] // J. Cosmet. Laser. Ther. 2004. № 6. R. 156-162; 23. Morton C.A., Scholefield R. D., Whitehurst O, Birch J. An open study to determine the efficacy of blue light in the treatment of mild to moderate acne // J. Dermatol. Surg. 2005. № 16. R. 219-223; 24. A multicenter clinical evaluation of the treatment of mild to moderate inflammatory acne vulgaris of the face with visible blue light in comparison to topical 1 % clindamycin antibiotic solution / M. H. Gold, J. Rao, M. P. Goldman [et al.] // J. Drugs. Dermatol. 2005. № 4. R. 6; 25. Macrophage responsiveness to light therapy / S. Young, P. Bolton, M. Dyson [et al.] // Lasers. Surg. Med. 1989. № 9. R. 497-505; 26. Laser stimulation of collagen synthesis in human skin fi-broblast cultures / T. S. Lam, R. P. Abergel, О A. Meeker [et al.] // Laser. Life. Sci. 1986. № 1. R. 61-77; 27. Low-intensity laser irradiation improves skin circulation in patients with diabetic microangiopathy /A. Schindl, M. Schindl, H. Scho'n [et al.] // Diabetes Care 1998. № 21. P. 580-584; 28. Karu T. I. Photobiological fundamentals of low-power laser therapy // J. Quantum. Electron. 1987. №23. R. 1703-1717; 29. Karu T. Primary and secondary mechanisms of action of visible to near-IR radiation on cells // J. Photochem. Photobiol. B. 1999. №49. R. 1-17; 30. In vitro effects of low-level laser irradiation at 660 nm on peripheral blood lymphocytes / I. Stadler, R. Evans, B. Kolb [et al.] // Lasers Surg. Med. 2000. № 27. R. 255-261; 31.YuW., Nairn J.O., Lanzafame R.J. Effects of photostim-ulation on wound healing in diabetic mice // Lasers. Surg. Med. 1997. №20. R. 56-63; 32. Yu W, Nairn J.O., Lanzafame R.J. The effect of laser irradiation on the release of bFGF from 3T3 fibroblasts // Photochem. Photobiol. 1994. № 59. R. 167-170; 33. Effect of NASA light-emitting diode irradiation on wound healing / H.T. Whelan, R.L. Smits, Jr., E.V. Buchman [et al.] // J. Clin. Laser. Med. Surg. 2001. № 19. R. 305-314; 34. NASA light-emitting diodes for the prevention of oral mucositis in pediatric bone marrow transplant patients / H.T. Whelan, J.F. Connelly, B.D. Hodgson [et al.] // J. Clin. Laser. Med. Surg. 2002. № 20. № 319-324; 35. Effect of NASA light-emitting diode irradiation on molecular changes for wound healing in diabetic mice / H.T. Whelan, E.V. Buchman, A. Dhokalia [et al.] // J. Clin. Laser. Med. Surg. 2003. № 21. R. 67-74; 36. Weiss R.A., Weiss M.A., Beasley K. L, Munavalli G. Our approach to non-ablative treatment of photoaging // Lasers. Surg. Med. 2005. № 37. R. 2-8; 37. Weiss R.A., McDaniel D. H., Geronemus R.G., Weiss M.A. Clinical trial of a novel non-thermal LED array for reversal of photoaging: Clinical, histologic, and surface profilo-metric results // Lasers. Surg. Med. 2005. № 36. R. 85-91; 38. Clinical experience with lightemitting diode (LED) photo-modulation / R.A. Weiss, D.H. McDaniel, R.G. Geronemus [et al.]//Lasers. Surg. Med. 2005. №31. R. 1199-1205; 39. Weiss R.A., Weiss M.A., Geronemus R.G., McDaniel D. H. A novel non-thermal non-ablative full panel LED photomod-ulation device for reversal of photoaging: Digital microscopic and clinical results in various skin types // J. Drugs. Dermatol. 2004. №3. R. 605-610; 40. Russell B.A., Kellett N., Reilly L. R. A study to determine the efficacy of combination LED light therapy (633 nm and 830 nm) in facial skin rejuvenation // J. Cosmet. Laser. Ther. 2005. № 7. R. 196-200; 41. Webster G. F. Inflammation in acne vulgaris// J.Am.Acad. Dermatol. 1995. № 33. R. 247-253; 42. Polymorphonuclear leukocyte lysosomal release in response to Propionibacterium acnes in vitro and its enhancement by sera from inflammatory acne patients / G. F. Webster, J. J. Leyden, C.C. Tsai [et al.] //J. Invest. Dermatol. 1980. № 74. R. 398-401; 43. Macrophage responsiveness to light therapy / S. Young, P. Bolton, M. Dyson [et al.] // Lasers. Surg. Med. 1989. № 9. R. 497-505; 44. Kjeldstad B. Different photoinactivation mechanisms in Propionibacterium acnes for near-ultraviolet and visible light // Photochem. Photobiol. 1987. № 46. R. 363-366; 45. Paithankar D.Y., Ross E.V., Saleh B.A., Blair M., Graham B. S. Acne treatment with a 1,450 nm wavelength laser and cryo-gen spray cooling // Lasers. Surg. Med. 2002. R. 31. R. 106-114; 46. Acne phototherapy using u.v.-free high intensity narrow band blue light: 3 centers clinical study /A.A. Shalita, Y. Harth, M. Elman [et al.] // Proc. SPIE. 2001. № 4244. R. 6173.